🇰🇷 South Korea Country × Condition
myocardial infarction Clinical Trials in South Korea
Active clinical trials for myocardial infarction with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT04416581 Phase 4
Recruiting
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Enrollment
3,320 pts
Country
🇰🇷 South Korea
Duk-Woo Park, MD
View Trial → NCT05770687
Recruiting
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Enrollment
1,000 pts
Country
🇰🇷 South Korea
Kiyuk Chang
View Trial → Frequently Asked Questions
How many myocardial infarction clinical trials are active in South Korea?
There are currently 2 active clinical trials for myocardial infarction with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a myocardial infarction clinical trial in South Korea?
To join a myocardial infarction clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are myocardial infarction trials in South Korea?
Active myocardial infarction trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology